Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Author's Takes
  • Reviews
    • View all reviews ...
    • Aging (Upcoming)
    • Next-Generation Sequencing in Medicine (Jun 2022)
    • New Therapeutic Targets in Cardiovascular Diseases (Mar 2022)
    • Immunometabolism (Jan 2022)
    • Circadian Rhythm (Oct 2021)
    • Gut-Brain Axis (Jul 2021)
    • Tumor Microenvironment (Mar 2021)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Commentaries
    • Concise Communication
    • Editorials
    • Viewpoint
    • Top read articles
  • Clinical Medicine
  • JCI This Month
    • Current issue
    • Past issues

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Author's Takes
  • In-Press Preview
  • Commentaries
  • Concise Communication
  • Editorials
  • Viewpoint
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Alerts
  • Advertising
  • Job board
  • Subscribe
  • Contact
Defining a role for the homeoprotein Six1 in EMT and mammary tumorigenesis
Derek C. Radisky
Derek C. Radisky
Published August 24, 2009
Citation Information: J Clin Invest. 2009;119(9):2528-2531. https://doi.org/10.1172/JCI40555.
View: Text | PDF
Commentary

Defining a role for the homeoprotein Six1 in EMT and mammary tumorigenesis

  • Text
  • PDF
Abstract

Homeobox (Hox) genes encode transcription factors that act as critical regulators of growth and differentiation during embryogenesis. While many studies have identified increased expression of Hox genes in tumors, much less is known about the mechanistic basis by which Hox genes facilitate tumor development. In this issue of the JCI, McCoy and colleagues show that transgenic mice that express the homeoprotein Six1 in mammary epithelial cells show increases in stem/progenitor cell populations and subsequent tumor development, while in a separate study Micalizzi and colleagues show that overexpression of Six1 facilitates breast cancer cell metastasis by inducing epithelial-mesenchymal transition (EMT) (see the related articles beginning on pages 2663 and 2678, respectively). Their findings implicate Six1 as a central mediator of breast cancer development.

Authors

Derek C. Radisky

×

Figure 1

Mammary tumor growth and metastasis is induced by overexpression of Six1.

Options: View larger image (or click on image) Download as PowerPoint
Mammary tumor growth and metastasis is induced by overexpression of Six1...
(i) Normal mammary epithelium consists of a bilayered epithelial structure of myoepithelial and luminal epithelial cells, surrounded by a continuous basement membrane. (ii) In their study in this issue of the JCI, McCoy et al. (15) show that transgenic mice that express Six1 under control of the mouse mammary tumor virus show induction of mammary ductal hyperplasia and growth of mammary tumors. Micalizzi et al. (16) in their study show that overexpression of Six1 in cultured human mammary epithelial cells leads to induction of EMT through stimulation of the TGF-β receptor and that, following xenograft implantation in immune-compromised mice, Six1-induced EMT facilitates tissue invasion and spread of these cells to the vasculature (iii) and formation of metastases in the lymph and bone (iv).

Copyright © 2022 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts